Galera Therapeutics Announces Extreme 1-for-200 Reverse Stock Split Effective July 12
GRTX has more than doubled off its 52-week low of $0.015.
Summary
Galera Therapeutics announced a 1-for-200 reverse stock split, effective July 12, 2026, with split-adjusted trading beginning July 13. This follows shareholder approval on May 11 for a reverse split within a 1:75 to 1:200 range. The company, which reported a going concern warning in Q1 2026 and is pursuing a dilutive merger, is taking an aggressive step to increase its per-share price. This extreme ratio is a critical move for the company's stock market viability, likely aimed at meeting exchange listing requirements given its current sub-$0.10 share price.
At the time of this announcement, GRTX was trading at $0.09 on OTC in the Life Sciences sector, with a market capitalization of approximately $18.3M. The 52-week trading range was $0.02 to $0.15. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.